关注
Jianyi Ding
标题
引用次数
引用次数
年份
IDH mutation in glioma: molecular mechanisms and potential therapeutic targets
S Han, Y Liu, SJ Cai, M Qian, J Ding, M Larion, MR Gilbert, C Yang
British journal of cancer 122 (11), 1580-1589, 2020
4692020
PHB associates with the HIRA complex to control an epigenetic-metabolic circuit in human ESCs
Z Zhu, C Li, Y Zeng, J Ding, Z Qu, J Gu, L Ge, F Tang, X Huang, C Zhou, ...
Cell stem cell 20 (2), 274-289. e7, 2017
382017
Targeting NRF2-Governed Glutathione Synthesis for SDHB-Mutated Pheochromocytoma and Paraganglioma
Y Liu, Y Pang, V Caisova, J Ding, D Yu, Y Zhou, TT Huynh, H Ghayee, ...
Cancers 12 (2), 280, 2020
312020
De novo generation of human hematopoietic stem cells from pluripotent stem cells for cellular therapy
J Ding, Y Li, A Larochelle
Cells 12 (2), 321, 2023
62023
Modulation of WNT, Activin/Nodal, and MAPK Signaling Pathways Increases Arterial Hemogenic Endothelium and Hematopoietic Stem/Progenitor Cell Formation During Human iPSC …
Y Li, J Ding, D Araki, J Zou, A Larochelle
Stem Cells 41 (7), 685-697, 2023
22023
CDK11 safeguards the identity of human embryonic stem cells via fine‐tuning signaling pathways
J Ding, Z Fang, X Liu, Z Zhu, C Wen, H Wang, J Gu, Q Li, R Zeng, H Li, ...
Journal of Cellular Physiology 235 (5), 4279-4290, 2020
22020
系统目前无法执行此操作，请稍后再试。
文章 1–6